NAT MED: Largest Alzheimer's-Related Protein Study Published To Date
-
Last Update: 2020-05-29
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
To date, our understanding of the pathophysiology of Alzheimer's disease (AD) has not been completerecently, researchers conducted the largest proteomics study of AD to date using quantitative mass spectrometry and co-expression network analysisresearchers have discovered a network of protein slots associated with sugar metabolism, one of the most significant lyses to AD pathology and cognitive impairmentThe module enriches aD genetic risk factors and small glial cells and star-shaped glial cell protein markers associated with anti-inflammatory states, indicating that the biological function sits on behalf of ADin the early stages of the disease, the protein in the module rises in cerebrospinal fluidin the study, which used quantitative proteomics to 2,000 brain and nearly 400 cerebrospinal fluid samples, researchers identified proteins and biological processes in the AD brain that could serve as therapeutic targets for the disease and as biomarkers of cerebrospinal fluid
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
